Divi's Laboratories Ltd.

•

divislabs.comBSE: 532488NSE: DIVISLAB

Market Cap₹ 2,47,576 Cr.

Current Price

High / Low₹ 9,615 / 5,636

Stock P/E84.6

Book Value₹ 665

Price to Book9.40

Dividend Yield0.32 %

ROCE21.5 %

ROE16.2 %

Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Company has consistently been profitable over the last 5 years
Latest quarter profit grew 65.5% YoY, showing strong momentum
Company has been maintaining a healthy dividend payout of 31.0%
Company has a consistent dividend-paying track record
Company generates healthy free cash flow

CONS

Company has delivered a poor profit growth of 5.3% over past five years
Stock is trading at 9.4x its book value
Expensive relative to growth - PEG of 7.0
Rich enterprise valuation - EV/EBITDA of 39.0x

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY NEXT 50 NIFTY PHARMA NIFTY100 QUALTY30 NIFTYLARGEMIDCAP250 NIFTY100 EQL WGT

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	BIOCON	390.95	128.63	63712.89	0.13	136.80	53.36	4336.00	10.89	3.26	19.54

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	1,778	1,909	1,855	2,303	2,118	2,338	2,319	2,585	2,410	2,715	2,604	2,831	3,080
	1,274	1,430	1,366	1,572	1,496	1,622	1,576	1,699	1,681	1,827	1,714	1,897	1,964
Operating Profit	504	479	489	731	622	716	743	886	729	888	890	934	1,116
OPM %	28.35%	25.09%	26.36%	31.74%	29.37%	30.62%	32.04%	34.27%	30.25%	32.71%	34.18%	32.99%	36.23%
	81	86	95	79	79	106	82	86	119	145	14	155	64
Interest	0	1	0	2	0	1	0	1	3	8	6	6	6
Depreciation	93	95	95	95	97	99	99	107	112	113	118	120	133
Profit before Tax	492	469	489	713	604	722	726	864	733	912	780	963	1,180
Tax %	27.64%	25.80%	26.79%	24.54%	28.81%	29.36%	18.87%	23.38%	25.65%	24.45%	25.26%	22.01%	23.56%
Net Profit	0	0	0	0	430	510	589	662	545	689	583	751	902
	13.41	13.11	13.50	20.25	16.20	19.20	22.20	24.93	20.49	25.97	21.98	28.31	33.95

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	4,064	3,891	4,946	5,394	6,969	8,960	7,767	7,845	9,360	10,560	11,230
	2,617	2,629	3,073	3,571	4,108	5,079	5,398	5,639	6,393	7,118	7,402
Operating Profit	1,447	1,263	1,873	1,823	2,861	3,881	2,369	2,206	2,967	3,442	3,828
OPM %	35.61%	32.45%	37.87%	33.80%	41.05%	43.32%	30.50%	28.12%	31.70%	32.59%	34.09%
	75	113	156	190	63	116	345	339	354	433	378
Interest	3	2	5	7	2	2	2	4	3	24	26
Depreciation	123	142	169	186	256	312	343	378	402	463	484
Profit before Tax	1,395	1,231	1,855	1,819	2,666	3,684	2,369	2,163	2,916	3,388	3,835
Tax %	24.00%	28.78%	27.08%	24.34%	25.57%	19.63%	23.01%	26.03%	24.86%	24.20%	23.73%
Net Profit	1,060	877	1,353	1,377	1,984	2,960	1,824	1,600	2,191	2,568	2,925
EPS	39.95	33.04	50.96	51.85	74.75	111.52	68.69	60.38	82.68	96.91	—
Dividend Payout %	25.03%	30.27%	31.40%	30.85%	26.76%	26.90%	43.59%	49.69%	36.28%	30.96%	—

COMPOUNDED SALES GROWTH

10 Years:: 11%
5 Years:: 9%
3 Years:: 11%

COMPOUNDED PROFIT GROWTH

10 Years:: 9%
5 Years:: 5%
3 Years:: 12%

STOCK PRICE CAGR

10 Years:: 22%
5 Years:: 13%
3 Years:: 35%
1 Year:: 55%

RETURN ON EQUITY

10 Years:: 19%
5 Years:: 17%
3 Years:: 15%
Last Year:: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	53	53	53	53	53	53	53	53	53	53
	5,304	5,872	6,904	7,257	9,242	11,675	12,714	13,518	14,916	16,708
	36	63	106	38	4	3	3	2	4	679
Trade Payables	446	411	492	591	763	796	762	824	910	1,211
	1,590	1,948	1,240	1,486	1,325	2,092	1,331	1,540	1,834	2,227
Total Liabilities	7,429	8,347	8,795	9,425	11,387	14,619	14,863	15,937	17,717	20,878
	1,559	1,996	2,088	2,782	3,704	4,325	4,722	4,739	5,442	6,528
Capital Work in Progress	444	120	492	920	711	470	212	778	1,022	2,113
	1,631	1,889	1,946	971	0	72	77	82	65	69
	1,320	1,351	1,772	1,864	2,145	2,829	3,000	3,184	3,236	3,954
	0	0	0	0	0	0	0	2,156	2,731	2,984
Cash & Bank	79	112	115	123	2,156	2,819	4,214	3,980	3,715	3,414
	2,396	2,879	2,382	2,766	2,671	4,105	2,638	1,018	1,506	1,816
Total Assets	7,429	8,347	8,795	9,425	11,387	14,619	14,863	15,937	17,717	20,878

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1,452	1,044	1,439	1,661	2,591	2,553	2,932	1,261	1,653	2,738
Cash from Investing	-1,140	-478	-685	-83	75	-2,195	-2,707	-269	-804	-2,219
Cash from Financing	2	-314	-246	-1,091	-35	-532	-797	-799	-799	-804
	13	-17	23	41	1,987	-816	-1,045	193	50	-285

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	51.90	51.89	51.89	51.89	51.89	51.89	51.88	51.88	51.88
	16.16	17.25	17.98	18.01	19.74	19.39	20.08	20.29	20.19
	21.66	20.98	20.44	20.63	18.96	19.68	19.18	19.13	19.29
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	10.18	9.80	9.59	9.39	9.32	8.96	8.76	8.60	8.54

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-12

Copy of Newspaper Publication

2026-09-12 - Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-10

Shareholders meeting

2026-08-10 - Divi's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 10, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.

2026-08-06

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-06 - Divi's Laboratories Limited has informed the Exchange about Transcript

2026-08-03

Copy of Newspaper Publication

2026-08-03 - Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-01

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-01 - Divi's Laboratories Limited has informed the Exchange about Link of Recording

2026-08-01

Change in Management

2026-08-01 - Divi's Laboratories Limited has informed the Exchange about change in Senior Management.

2026-08-01

Outcome of Board Meeting

2026-08-01 - Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-31

Retirement

2026-07-31 - Divi's Laboratories Limited has informed the Exchange about Retirement of Senior Management Personnel.

2026-07-24

Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-24 - Divi's Laboratories Limited has informed the Exchange about Schedule of meet

News

Recent coverage and analyst commentary for DIVISLAB

Loading news…

🤖

AI Stock Analyst

Divi's Laboratories Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

BIOCON

390.95

128.63

63712.89

0.13

136.80

53.36

4336.00

10.89

3.26

19.54

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

1,778

1,909

1,855

2,303

2,118

2,338

2,319

2,585

2,410

2,715

2,604

2,831

3,080

1,274

1,430

1,366

1,572

1,496

1,622

1,576

1,699

1,681

1,827

1,714

1,897

1,964

Operating Profit

504

479

489

731

622

716

743

886

729

888

890

934

1,116

OPM %

28.35%

25.09%

26.36%

31.74%

29.37%

30.62%

32.04%

34.27%

30.25%

32.71%

34.18%

32.99%

36.23%

106

119

145

155

Interest

Depreciation

107

112

113

118

120

133

Profit before Tax

492

469

489

713

604

722

726

864

733

912

780

963

1,180

Tax %

27.64%

25.80%

26.79%

24.54%

28.81%

29.36%

18.87%

23.38%

25.65%

24.45%

25.26%

22.01%

23.56%

Net Profit

430

510

589

662

545

689

583

751

902

13.41

13.11

13.50

20.25

16.20

19.20

22.20

24.93

20.49

25.97

21.98

28.31

33.95

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

4,064

3,891

4,946

5,394

6,969

8,960

7,767

7,845

9,360

10,560

11,230

2,617

2,629

3,073

3,571

4,108

5,079

5,398

5,639

6,393

7,118

7,402

Operating Profit

1,447

1,263

1,873

1,823

2,861

3,881

2,369

2,206

2,967

3,442

3,828

OPM %

35.61%

32.45%

37.87%

33.80%

41.05%

43.32%

30.50%

28.12%

31.70%

32.59%

34.09%

113

156

190

116

345

339

354

433

378

Interest

Depreciation

123

142

169

186

256

312

343

378

402

463

484

Profit before Tax

1,395

1,231

1,855

1,819

2,666

3,684

2,369

2,163

2,916

3,388

3,835

Tax %

24.00%

28.78%

27.08%

24.34%

25.57%

19.63%

23.01%

26.03%

24.86%

24.20%

23.73%

Net Profit

1,060

877

1,353

1,377

1,984

2,960

1,824

1,600

2,191

2,568

2,925

EPS

39.95

33.04

50.96

51.85

74.75

111.52

68.69

60.38

82.68

96.91

—

Dividend Payout %

25.03%

30.27%

31.40%

30.85%

26.76%

26.90%

43.59%

49.69%

36.28%

30.96%

—

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

5,304

5,872

6,904

7,257

9,242

11,675

12,714

13,518

14,916

16,708

106

679

Trade Payables

446

411

492

591

763

796

762

824

910

1,211

1,590

1,948

1,240

1,486

1,325

2,092

1,331

1,540

1,834

2,227

Total Liabilities

7,429

8,347

8,795

9,425

11,387

14,619

14,863

15,937

17,717

20,878

1,559

1,996

2,088

2,782

3,704

4,325

4,722

4,739

5,442

6,528

Capital Work in Progress

444

120

492

920

711

470

212

778

1,022

2,113

1,631

1,889

1,946

971

1,320

1,351

1,772

1,864

2,145

2,829

3,000

3,184

3,236

3,954

2,156

2,731

2,984

Cash & Bank

112

115

123

2,156

2,819

4,214

3,980

3,715

3,414

2,396

2,879

2,382

2,766

2,671

4,105

2,638

1,018

1,506

1,816

Total Assets

7,429

8,347

8,795

9,425

11,387

14,619

14,863

15,937

17,717

20,878

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

1,452

1,044

1,439

1,661

2,591

2,553

2,932

1,261

1,653

2,738

Cash from Investing

-1,140

-478

-685

-83

-2,195

-2,707

-269

-804

-2,219

Cash from Financing

-314

-246

-1,091

-35

-532

-797

-799

-804

-17

1,987

-816

-1,045

193

-285

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

51.90

51.89

51.88

16.16

17.25

17.98

18.01

19.74

19.39

20.08

20.29

20.19

21.66

20.98

20.44

20.63

18.96

19.68

19.18

19.13

19.29

Government

0.00

10.18

9.80

9.59

9.39

9.32

8.96

8.76

8.60

8.54

Divi's Laboratories Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Divi's Laboratories Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI